After giving informed written consent, patients underwent electrophysiological testing after an overnight fast. Patients were locally anesthetized (with 0.25% bupivacaine) and sedated with intravenous midazolam and fentanyl. Quadripolar 6F catheters were advanced to the His bundle position and right ventricular apex. Right atrial electrogram recordings were obtained with either a quadripolar catheter positioned © 2014 American Heart Association, Inc. Original Article
I diopathic ventricular tachycardias (VTs) most often originate from the right ventricular outflow tract. 1 Its mechanism has been shown to be because of cAMP-mediated triggered activity. 2 Another common area of origin for idiopathic ventricular arrhythmias is the ventricular aspect of the tricuspid and mitral annuli. The mechanism of these arrhythmias has not yet been studied systematically because most of these patients present with frequent premature ventricular contractions (PVCs) alone, [3] [4] [5] [6] precluding a comprehensive evaluation of the method of tachycardia initiation and termination, including the response to programmed stimulation with or without isoproterenol infusion, cessation with adenosine or vagal maneuvers, and sensitivity to β-blockade and verapamil.
Clinical Perspective on p 444
The atrial aspect of the tricuspid and ventricular annuli are also frequent sites of focal atrial tachycardia (AT). [7] [8] [9] [10] We have previously demonstrated that tricuspid and mitral annular ATs are because of cAMP-dependent triggered activity. 9, 10 Based on the current understanding of cardiac conduction system development and the observed propensity of arrhythmogenic foci to originate in areas near the atrioventricular annuli, which may reflect a common pathophysiological process, we hypothesized that idiopathic annular VT share a common mechanism with AT. We prospectively evaluated this hypothesis in patients with sustained atrial and ventricular annular tachycardia (peri-annular tachycardia).
Methods

Patient Characteristics
The study group consists of 49 consecutive patients with sustained, focal peri-annular tachycardia undergoing invasive electrophysiology study at our institution in whom the effects of adenosine on tachycardia could be reliably evaluated. None of the patients was reported in our previous studies. [9] [10] [11] Baseline characteristics of the patients, including age, sex, cardiac history, and left ventricular ejection fraction (LVEF) were collected. Structural heart disease was defined as the presence of coronary artery disease (>60% occlusion), a LVEF of ≤45%, or moderate/severe valvular disease. This study was approved by the Weill Cornell Medical College Institutional Review Board.
in the high right atrium or a 7F duodecapolar halo catheter positioned along the tricuspid annulus. A 6F decapolar catheter was positioned in the coronary sinus to record left atrial activity along the mitral annulus. Tachycardia mechanism was evaluated by a previously published schema. 11 The mode of tachycardia initiation, termination, sensitivity to catecholamine infusion, and response to adenosine and verapamil were evaluated. The stimulation protocol included rapid atrial and ventricular pacing and introduction of atrial and ventricular extrastimuli at several basic drive cycle lengths. To facilitate induction of sustained tachycardia, when necessary, programmed stimulation was repeated during isoproterenol infusion at a dose sufficient to decrease the sinus cycle length by ≈30%. All but 2 patients underwent electroanatomic mapping using the Biosense CARTO system (Biosense-Webster, Diamond Bar, CA) or the St. Jude Medical NAVX system (Saint Paul, MN).
Focal Tachycardia Diagnosis
AT was distinguished from other supraventricular tachycardias, including atrioventricular nodal re-entry and atrioventricular reciprocating tachycardia, by standard electrophysiological criteria. Focal AT was defined based on the following characteristics: (1) centrifugal atrial activation pattern, (2) early local atrial activation relative to the surface P wave, and (3) atrial activation map encompassing <50% of tachycardia cycle length. Annular focal AT was identified when the above criteria were met, fluoroscopic and 3-dimensional electroanatomic sites were consistent with an annular site, and both an atrial and ventricular electrogram were present at the site of successful ablation. A location was considered para-Hisian when either a His deflection was observed at the site of earliest atrial activation during tachycardia or the successful ablation site along the tricuspid annulus was within 1 cm of a site recording the His bundle potential.
Pharmacological Evaluation
Adenosine (Adenocard; Fujisawa, Deerfield, IL) was administered to all patients during tachycardia, as a rapid bolus through a central venous catheter, followed by a 10-mL flush of normal saline. Sensitivity (termination or transient suppression) or insensitivity was noted. The response to verapamil was also evaluated in 2 patients during VT, as was the response to Valsalva in 2 other patients.
Catheter Ablation
Catheter ablation was performed using either radiofrequency or cryoablation. Radiofrequency energy was applied using a nonirrigated 7F 4-mmtip ablation catheter (Biosense-Webster) with a target temperature of 60°C and a maximal allowed power output of 50 W or a 3.5-mm (Thermocool, Biosense-Webster) or 4-mm (Safire BLU, St. Jude Medical) open-irrigation ablation catheter at power settings between 15 and 45 W for 30 to 60 seconds using a power-controlled mode with an irrigation rate of 17 to 30 mL per minute. Cryoablation was performed in 3 patients with paraHisian AT using a 4-mm-tip ablation catheter with a target temperature of −80°C. Energy was applied for ≤4 minutes at each location.
Statistics
Results are presented as mean±SD where appropriate. Comparison of patients with AT and VT was performed using the 2-tailed t test for continuous variables and the χ 2 test for categorical variables. P<0.05 was considered statistically significant.
Results
Patient Characteristics
The baseline characteristics of the patients are listed in Tables 1  and 2 . The mean age was 58.0±16.4 years and 45% of the patients were women. All patients were treated within 1 year of presentation. The mean LVEF was 56.7±11.8%; 7 patients had LVEF ≤45%. Only 1 of 9 patients with VT had an LVEF of ≤45%. This patient also had frequent PVCs and her ejection fraction normalized postablation. Of the 40 patients with AT, only 6 patients had LVEF ≤45%, 3 of whom had complete recovery of LVEF after ablation (presumably because of resolution of tachycardiainduced cardiomyopathy) and 2 others were lost to follow-up.
Twenty-one (43%) patients had hypertension and 4 (8.2%) had coronary artery disease, and 3 underwent previous cardiac surgery. One (patient no. 14) was on an antiarrhythmic drug (sotalol) at the time of the procedure. Nine annular VTs and 41 annular ATs (in 40 patients) were identified. A schematic of their various locations is shown in Figure 1 . Eight of the 9 patients with VT presented with sustained VT, and 1 patient presented with a PVC-induced cardiomyopathy.
Comparison of Groups
There was no significant difference between patients with VT compared with patients with AT in age (55.7±20.0 versus 58.6±15.7 years, respectively; P=NS) or sex (56% versus 48% women, respectively; P=NS) or ejection fraction (57.4±9.8 versus 56.4±12.5, respectively; P=NS). All periannular tachycardias responded to adenosine and there was no significant difference in ablation success (89 versus 95%, respectively; P=NS).
Electrophysiological Characteristics
In 3 of the 9 patients with sustained annular VT, the arrhythmia originated from the tricuspid annulus (Figure 2) , and in 6 patients, VT originated from the mitral annulus (Figure 3) . Three of the annular VTs were epicardial in origin (2 from the mitral annulus, 1 from the tricuspid annulus; Figure 4 ). The mean VT cycle length was 450±87 ms. In 6 of the 9 patients, programmed stimulation initiated or terminated tachycardia (programmed stimulation was not evaluated in 3 patients with VT who were in incessant tachycardia). Isoproterenol facilitated initiation of tachycardia in 7 of the 9 (77.8%) patients. All the 9 VTs terminated with adenosine (mean dose 12.7±5.6 mg). Verapamil terminated VT in the 2 patients in whom it was administered ( Figure 3A) . Valsalva terminated VT in 2 patients ( Figure 4B ).
Of the 41 cases of annular AT, 4 were localized to the mitral annulus ( Figure 5 ) and 37 to the tricuspid annulus ( Figure 6 ; including 9 para-Hisian). One patient had both an anterior mitral annular and a septal tricuspid annular AT. The mean tachycardia cycle length was 412±77 ms. In all 41 ATs, programmed stimulation initiated or terminated tachycardia. Isoproterenol was required to facilitate initiation of tachycardia in 28 of 41 (68.3%) of annular ATs. Adenosine terminated sustained AT in all cases with a mean dose of 8.9±3.1 mg.
The mechanism of all tachycardias was consistent with triggered activity as demonstrated by reproducible initiation and termination with programmed stimulation (94%) and sensitivity to adenosine (Figures 2A, 4B , 5A, and 6A), verapamil ( Figure 3A) , and Valsalva maneuvers ( Figure 4B ). In addition, catecholamine infusion facilitated induction of tachycardia in 64% of patients. Features of enhanced automaticity (ie, spontaneous initiation and termination, failure to initiate with programmed stimulation, and demonstration of warm-up and cool-down phenomena) and microreentry (ie, entrainment and fractionated electrograms at the origin of tachycardia) were absent.
Of note, 1 patient in this study presented with a PVC-induced cardiomyopathy (43% PVC prevalence; patient no. 5; Table 1 ). Although the patient had no evidence of clinical sustained VT, during electrophysiological study, sustained VT was induced with programmed stimulation during concurrent isoproterenol infusion ( Figure 7B ). The induced VT and clinical PVCs had an identical QRS morphology ( Figure 7C ). The PVC was targeted for ablation, which also eliminated induction of VT.
Tachycardia Mapping and Catheter Ablation
Three-dimensional activation mapping was performed in all but 2 patients. Activation mapping demonstrated a centrifugal activation pattern, consistent with focal activation. Catheter ablation was successful in 38 of 40 (95%) patients with annular AT and 8 of 9 patients with annular VT. One case of AT along the posterolateral tricuspid annulus remained inducible despite attempted ablation, and another case was not targeted for ablation because the clinical arrhythmia was atrioventricular nodal re-entrant tachycardia. In 5 patients, mapping and ablation were performed in the noncoronary cusp of the aortic valve for para-Hisian AT.
Discussion
The atrioventricular continuity is an area enriched with arrhythmogenic foci. This is the first study to systematically characterize the mechanism of sustained, peri-annular VT and to compare the electrophysiological properties of peri-annular VT and AT. The major finding of this study is that these arrhythmias share a common electrophysiological mechanism, irrespective of atrial or ventricular annular origin. These arrhythmias are focal in origin, inducible with programmed stimulation, facilitated by catecholamines and sensitive to adenosine, verapamil and Valsalva maneuvers. These shared electrophysiological findings are mechanistically consistent with cAMP-mediated triggered activity because of intracellular calcium overload. The contiguous location of these atrial and ventricular arrhythmias and identical mechanism suggest a common developmental origin. These arrhythmogenic cells may arise from a common source, located on either the atrial or ventricular aspect of the annulus, which ultimately determines the phenotype of tachycardia.
Tachycardia Phenotype
In our series, these tachycardias more often originated on the atrial aspect of the annuli, with the tricuspid annulus being a more common site than the mitral annulus ( Figure 1 ). All patients in our study had sustained tachycardia. Nearly all studies published to date on ventricular annular arrhythmias comprise patients with frequent PVCs, not sustained arrhythmias. This unique circumstance of our study offered an opportunity to formally investigate mechanism. Of the 9 patients with inducible sustained VT, 8 had clinically documented sustained VT (3 of which were exercise-induced). One patient had ambulatory monitoring before electrophysiological evaluation that showed frequent PVCs (43% prevalence). In this patient, the PVCs were uniform in morphology and had a morphology similar to that of the sustained clinical and inducible VT in the laboratory, suggesting that the PVC may have had a similar electrophysiological mechanism ( Figure 7 ).
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Proposed Embryonic Origin of Annular Tachycardia
The primary heart tube, derived from heart progenitor cells of the first heart field, gives rise to the left ventricle, a portion of the atria and the atrioventricular canal. The embryonic atrioventricular canal comprises precursors of the atrioventricular node and atrioventricular ring bundles, the latter of which encircle the orifices of the tricuspid and mitral valves and emerge from inferior extensions of the compact atrioventricular node. 13 The atrioventricular ring, in contrast to working myocardium, expresses Tbx3, Hcn4, and Cx45 and is negative for Cx40, Cx43, and Nav1.5.
14 Typically, during the latter phases of development, expression of markers like Tbx3 and mink-lacZ become limited to the atrioventricular node, whereas the remainder of the atrioventricular canal undergoes apoptosis or differentiation into working myocardium. 15 However, vestiges of primitive myocardium from the atrioventricular canal, resembling nodal cells, may persist circumferentially along the atrioventricular valves in the adult human heart. 16 This may result from incomplete regression of embryonic tissue or re-expression of the embryonic gene program, and provides a possible substrate for the tachycardias described in our study. To this end, multiple studies have confirmed nodal-like action potentials along the atrioventricular valves. [17] [18] [19] These cells histologically resemble atrial cells but lack Cx43, and respond to adenosine in a manner similar to atrioventricular nodal cells, with a decrease in action potential amplitude and duration. Furthermore, a zone of cells with action potential characteristics intermediate between atrial and atrioventricular nodal cells is interposed along a 1-cm rim around the annuli, which also respond to adenosine. 19 Although speculative, some inferences can be drawn with regard to the mechanism of arrhythmia in our study. Nodal-like cells in the peri-annular region can demonstrate spontaneous firing, suggesting the possibility of automaticity. However, we think this mechanism is unlikely applicable to our study because the arrhythmias were reproducibly initiated and terminated with programmed stimulation. Furthermore, adenosine terminated the arrhythmias rather than transiently suppressing them. Both of these findings are inconsistent with an automatic mechanism.
Another possibility is that the arrhythmias are due to triggered activity. In support of this hypothesis, isolated preparations of muscle fibers from the mitral valve demonstrate sustained arrhythmias due to delayed after depolarizations and triggered activity. 18, 19 In these studies, the arrhythmias initiate with rapid pacing or catecholamines and terminate with single extrastimuli, verapamil or acetylcholine. Similarly, the arrhythmias in our study were focal in origin, initiated with programmed stimulation, and were responsive to adenosine and verapamil, findings consistent with a triggered mechanism.
It is notable that many adult atrial arrhythmias originate from corresponding regions in the developing heart that do not initially differentiate into working myocardium. These areas express Tbx2 and Tbx3, which inhibit differentiation of primary/embryonic myocytes, capable of nodal activity, into working myocardium. This is mediated by repression of chamber-specific gene programs. These regions include structures derived from the sinus venosus, including the crista terminalis and structures derived from the atrioventricular canal (ie, the myocardium encircling the tricuspid and mitral valves). As identified above, triggered activity has been shown to occur in the tricuspid and mitral annuli, 19 and the crista terminalis is also a common source of triggered activity in isolated preparations 20 and clinically in humans. 9, 21 It has been proposed that these arrhythmias may owe their origin to a common primary myocardial lineage. 15, 19, 22 Mechanistically, there may be an important link between nodal-like cells capable of both automaticity and triggered activity. For instance, normal automaticity in nodal cells that populate the sinoatrial node is thought to be due to a membrane voltage clock as well as to a calcium clock. Under normal conditions, spontaneous release of local intracellular Ca 2+ from the sarcoplasmic reticulum activates the electrogenic sodium-calcium exchanger (I NCX ) to produce a net inward positive depolarizing diastolic current. 23 However, under conditions that produce a critical degree of intracellular calcium overload, such as during catecholamine stimulation, this same cellular process is augmented, eliciting triggered activity within the sinoatrial node. 24 A similar mechanism may be operative in dormant nodal-like remnant cells surrounding the tricuspid and mitral annuli. Therefore, although these tissues may support both automaticity and triggered activity, our data suggest that triggered activity is the more clinically prevalent mechanism.
Our findings also suggest that peri-annular tissue can give rise not only to AT but also to VT. We surmise that this is related to an arrhythmogenic focus that originates from the inferior aspect of either annulus, and therefore activates ventricular rather than atrial myocardium.
Limitations
Although the preponderance of evidence suggests that the mechanism of arrhythmogenesis of annular tachycardia is triggered activity, it is possible that re-entry could account for some of these arrhythmias. However, adenosine does not terminate macroreentrant atrial or ventricular tacycardia or that because of microreenty. 11 Nevertheless, it is important to acknowledge that, although the majority of the patients in this study did not have structural heart disease based on echocardiography, and the single patients with VT with cardiomyopathy did not have myocardial scar detected with cardiac MRI (and left ventricular function subsequently improved after ablation), we cannot exclude the possibility that some patients may have had an underlying subclinical substrate of nonischemic cardiomyopathy with peri-annular scar 25 because cardiac MRI imaging was performed in a minority of patients.
Because some of the tachycardias were difficult to induce despite provocative measures and the indication for the study was ablation of clinical VT, verapamil was not given to all patients. However, the administration and termination in 2 of 2 patients with VT provides data to support the proposed mechanism of triggered activity. In 3 patients with VT (no. 2, no. 7 and no. 9) inducibility and termination of tachycardia was not systematically evaluated. Therefore, we cannot definitively conclude that these cases were because of triggered activity; however, based on their pharmacological responses and location, we think this is a reasonable, albeit speculative, conclusion.
Conclusions
The present study demonstrates that the tissue surrounding the tricuspid and mitral annuli is enriched with arrhythmogenic foci, which can manifest as focal atrial or VT. The sensitivity of these tachycardias to adenosine provides insight into a shared arrhythmia mechanism, one that is because of intracellular calcium overload and triggered activity, findings consistent with a common myocardial lineage. 
